The patent status of Mirabegron is a key factor in its market presence and the potential for generic competition.
When does Mirabegron's patent exclusivity expire?
The primary patents for Mirabegron, marketed as Myrbetriq and Betmiga, have expired. For example, U.S. Patent No. 8,822,460, which was a significant patent for the drug, expired in 2023 [1]. DrugPatentWatch.com tracks these expiration dates, noting that many of the core patents for Mirabegron have now lapsed [2].
Can generic versions of Mirabegron be sold now?
With the expiry of key patents, generic versions of Mirabegron are becoming available or are expected to become available. This typically allows for the introduction of lower-cost alternatives to the branded medication.
What happens after Mirabegron patents expire?
Following patent expiry, the market typically opens up to generic drug manufacturers. This usually leads to increased competition and a reduction in drug prices. Patients may find more affordable options for Mirabegron, and healthcare systems can see cost savings.
Who manufactures generic Mirabegron?
Several generic pharmaceutical companies are likely to enter or have already entered the market with their versions of Mirabegron following patent expirations. Specific manufacturers would typically be listed on regulatory agency websites or pharmaceutical distribution platforms.
What is Mirabegron used for?
Mirabegron is a medication used to treat overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency [3]. It works by relaxing the detrusor muscle, which is the bladder muscle, allowing the bladder to hold more urine [3].
How does Mirabegron work?
Mirabegron is a beta-3 adrenergic agonist. It selectively activates beta-3 adrenergic receptors in the detrusor muscle of the bladder. This activation leads to smooth muscle relaxation, increasing bladder capacity and reducing the frequency and urgency associated with OAB [3].
What are the side effects of Mirabegron?
Common side effects of Mirabegron can include high blood pressure, nasopharyngitis (common cold symptoms), urinary tract infection, and constipation [3]. Less common but more serious side effects can occur, and patients should consult their healthcare provider regarding potential risks.
How does Mirabegron compare to other OAB treatments?
Mirabegron offers a different mechanism of action compared to traditional anticholinergic OAB medications. While anticholinergics work by blocking acetylcholine, Mirabegron relaxes the bladder muscle. This difference in mechanism can be important for patients who experience bothersome side effects from anticholinergics or who do not respond adequately to them.
What is the typical cost of Mirabegron?
The cost of Mirabegron can vary depending on the dosage, quantity, and insurance coverage. Before patent expiry, the branded versions were typically more expensive. With the introduction of generics, the cost is expected to decrease significantly.
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.drugpatentwatch.com/drug/mirabegron
[3] https://www.nhs.uk/medicines/mirabegron/